Seasonal influenza
Seasonal influenza, usually called flu, is a respiratory infection caused mainly by influenza A and B viruses. It circulates worldwide. Outbreaks occur mainly in winter in temperate climates, while tropical regions can have flu throughout the year. It spreads easily between people, especially in crowded settings, through droplets released by coughing or sneezing and through contaminated hands. Symptoms usually start 1–4 days after infection. They include sudden fever, cough, sore throat, body aches and marked tiredness. Most people recover within about a week, although cough can last longer. Flu can also cause pneumonia, worsen existing illnesses, and lead to hospitalization or death. Pregnant people, young children, older adults and people with certain long-term conditions are at greater risk. Vaccines and antiviral medicines are available. WHO identifies vaccination as the best way to prevent flu. The most recent seasonal-influenza WHO notice retrieved for this page was dated 2025-12-10; it does not establish the situation on 2026-11-15.
Key facts
| Transmission | Person-to-person spread through droplets released by coughing or sneezing; contaminated hands can also spread the virus. Transmission is rapid in crowded settings. |
|---|---|
| Incubation | 1–4 days, usually about 2 days, according to WHO. |
| Case fatality | Unknown from the retrieved sources; no comparable estimates with and without treatment were available. WHO estimates 290,000–650,000 influenza-associated respiratory deaths annually worldwide, which is not a case-fatality rate. |
| Reproduction number | Unknown from the retrieved evidence. A 2014 systematic review was found, but its numerical results were not accessible. |
| Vaccine | Available. WHO identifies vaccination as the best prevention measure. Its 2025-12-10 notice reported early evidence of protection against hospital attendance despite uncertainty about protection against clinical disease that season. |
| Treatment | Rest, fluids and symptom relief for uncomplicated illness; medical care for severe illness or people with risk factors. Antiviral medicines, including oseltamivir and zanamivir, are available. |
| Reservoir | Humans sustain circulation of seasonal influenza A and B viruses. Animal-origin influenza infections are distinct from routine seasonal flu. |
| Endemic regions | Worldwide; mainly winter epidemics in temperate climates and year-round, less regular activity in tropical regions. |
Transmission
Seasonal flu spreads easily between people. WHO describes virus-containing droplets released when an infected person coughs or sneezes as a route of infection for people nearby. Hands contaminated with influenza viruses can also spread infection. Crowded places, including schools and nursing homes, can support rapid transmission. Health and care workers have greater exposure through their work and can pass infection to vulnerable people. Covering coughs and washing hands regularly are WHO-recommended prevention measures. Symptoms generally begin 1–4 days after infection, usually around 2 days. The retrieved evidence does not provide a usable numerical reproduction number or household secondary attack rate.
Symptoms and severity
Flu often begins suddenly, with fever, a usually dry cough, headache, muscle and joint pain, sore throat, runny nose and feeling very unwell. Most people recover from fever and other symptoms within a week, but cough can last 2 weeks or more. Severe illness can include pneumonia and sepsis, a dangerous response to infection. Flu can also worsen existing medical conditions. Higher-risk groups include pregnant people, children under 5, older adults and people with chronic illnesses or weakened immune systems. WHO estimates 3–5 million severe cases and 290,000–650,000 respiratory deaths worldwide annually. These are annual burden estimates, not the chance that an individual infected person will die.
Treatment and vaccines
Most people with uncomplicated flu recover without specific treatment. WHO recommends rest, plenty of liquids and care aimed at relieving symptoms. People with severe symptoms or underlying medical problems should seek medical care. Antiviral medicines are available, including oseltamivir and zanamivir; the retrieved literature documents their use but does not provide enough results to quantify their benefits here. Vaccination is WHO’s preferred prevention measure. In its 2025-12-10 notice, WHO reported early evidence that vaccines continued to protect children and adults against hospital attendance during that season. Protection against clinical illness remained uncertain. That assessment should not be treated as a measurement of vaccine performance in the 2026 season.
- Influenza (seasonal) WHO
- Influenza virus resistance to neuraminidase inhibitors. Europe PMC · 22 Mar 2013
- Seasonal influenza - Global situation WHO · 10 Dec 2025
Where it occurs
Seasonal influenza occurs worldwide, not just in places reporting an unusual outbreak. In temperate climates, epidemics occur mainly during winter. In tropical regions, influenza can circulate throughout the year and cause outbreaks at less regular intervals. Timing, duration and intensity differ between countries and seasons. WHO’s 2025-12-10 notice described rising northern-hemisphere activity, unusually long seasons in some southern-hemisphere countries, and sustained tropical activity during parts of 2025. Those observations describe that period rather than current conditions everywhere. Influenza A and B viruses cause seasonal epidemics. Animal-origin influenza notices returned by the search concern a different public-health problem and should not be used to describe the geographic burden or severity of ordinary seasonal flu.
- Influenza (seasonal) WHO
- Seasonal influenza - Global situation WHO · 10 Dec 2025
Recent history
Open Outbreak’s archive lookup returned 0 events for the respiratory-season key. The supplied site record lists “Respiratory season (influenza, COVID-19, RSV)” as active. This archive count reflects site coverage, not an absence of influenza outbreaks. The latest seasonal-flu WHO notice retrieved was dated 2025-12-10. It reported increasing global activity, with influenza A(H3N2) predominant, and a rapid rise in a genetically distinct group called subclade K since August 2025. WHO said activity remained within expected seasonal ranges globally, although some regions had earlier or higher activity than usual. Available data then did not indicate increased disease severity. No retrieved seasonal-flu notice establishes conditions as of 2026-11-15.
- Seasonal influenza - Global situation WHO · 10 Dec 2025
What to watch
Important signals include unusually early, prolonged or intense activity in a region, rising hospital demand, and evidence that circulating viruses cause more severe disease. New virus groups warrant monitoring, but genetic change alone does not establish greater severity: WHO made that distinction for subclade K in 2025. Sustained person-to-person spread is already normal for seasonal flu; a novel animal-origin virus acquiring such spread would be a different concern. Antiviral resistance and reduced vaccine protection also matter. Public-health planning should track vaccine availability and access, especially for high-risk groups, although no supply shortage was documented in the retrieved sources. Flu, COVID-19 and RSV can produce similar symptoms, so testing and surveillance help distinguish their contributions.
- Seasonal influenza - Global situation WHO · 10 Dec 2025
- Influenza (seasonal) WHO
- Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance. Europe PMC · 1 Jan 2013
- Influenza virus resistance to neuraminidase inhibitors. Europe PMC · 22 Mar 2013
Related outbreaks
- Respiratory season (influenza, COVID-19, RSV) Attention: high